Entering text into the input field will update the search result below

Mydecine Innovations Group announces 1-for-50 reverse stock split

  • Biotechnology company Mydecine Innovations Group (OTCPK:MYCOF) on Wednesday announced a 1-for-50 reverse stock split, wherein every 50 common shares will be consolidated into 1 common share.
  • The reverse stock split is expected to result in Mydecine's outstanding common shares being reduced from 268.5M to about 5.4M.
  • The expected effective date of the split will be April 20, and the post-consolidation common shares will start trading on the NEO exchange as of April 21.

Recommended For You

About MYCOF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MYCOF--
Mydecine Innovations Group Inc.